Exact Mass: 786.3628

Exact Mass Matches: 786.3628

Found 78 metabolites which its exact mass value is equals to given mass value 786.3628, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N1,N5,N10,N14-Tetra-trans-p-coumaroylspermine

(2E)-N-{3-[(2E)-N-{4-[(2E)-N-(3-{[(2E)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}propyl)-3-(4-hydroxyphenyl)prop-2-enamido]butyl}-3-(4-hydroxyphenyl)prop-2-enamido]propyl}-3-(4-hydroxyphenyl)prop-2-enimidate

C46H50N4O8 (786.3628)


N1,N5,N10,N14-Tetra-trans-p-coumaroylspermine is found in herbs and spices. N1,N5,N10,N14-Tetra-trans-p-coumaroylspermine is a constituent of Matricaria chamomilla (German chamomile). Constituent of Matricaria chamomilla (German chamomile). N1,N5,N10,N14-Tetra-trans-p-coumaroylspermine is found in herbs and spices.

   

PGP(i-12:0/18:1(12Z)-O(9S,10R))

[(2S)-2-hydroxy-3-({hydroxy[(2R)-3-[(10-methylundecanoyl)oxy]-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C36H68O14P2 (786.4084)


PGP(i-12:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(i-12:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(18:1(12Z)-O(9S,10R)/i-12:0)

[(2S)-2-hydroxy-3-({hydroxy[(2R)-2-[(10-methylundecanoyl)oxy]-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C36H68O14P2 (786.4084)


PGP(18:1(12Z)-O(9S,10R)/i-12:0) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(18:1(12Z)-O(9S,10R)/i-12:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(i-12:0/18:1(9Z)-O(12,13))

[(2S)-2-hydroxy-3-({hydroxy[(2R)-3-[(10-methylundecanoyl)oxy]-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C36H68O14P2 (786.4084)


PGP(i-12:0/18:1(9Z)-O(12,13)) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(i-12:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

PGP(18:1(9Z)-O(12,13)/i-12:0)

[(2S)-2-hydroxy-3-({hydroxy[(2R)-2-[(10-methylundecanoyl)oxy]-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphoryl}oxy)propoxy]phosphonic acid

C36H68O14P2 (786.4084)


PGP(18:1(9Z)-O(12,13)/i-12:0) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(18:1(9Z)-O(12,13)/i-12:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396).

   

Diospolysaponin A

(23S,25R)-12alpha,14alpha,17alpha,23-tetrahydroxyspirost-5-en-3beta-yl O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside

C39H62O16 (786.4038)


   
   

Cratoxyarborequinone B

Cratoxyarborequinone B

C49H54O9 (786.3768)


   
   

(2E,6Z)-2,6-dimethyl-8-[(O-beta-D-glucopyranosyl-(1->2)-alpha-L-rhamnopyranosyl)-oxy]-octadien-1-yl O-beta-D-glucopyranosyl-(1->2)-alpha-L-rhamnopyranoside

(2E,6Z)-2,6-dimethyl-8-[(O-beta-D-glucopyranosyl-(1->2)-alpha-L-rhamnopyranosyl)-oxy]-octadien-1-yl O-beta-D-glucopyranosyl-(1->2)-alpha-L-rhamnopyranoside

C34H58O20 (786.3521)


   
   

AS-186d

AS-186d

C44H50O13 (786.3251)


A dibenzodioxonine isolated from the culture broth of Penicillium asperosporum that acts as an acyl-CoA:cholesterol acyltransferase inhibitor.

   
   

26-O-beta-D-glucopyranosyl-2alpha,3beta,22xi-trihydroxy-furost-5,25(27)-diene-1beta-yl O-beta-D-galactopyranoside|atropuroside F

26-O-beta-D-glucopyranosyl-2alpha,3beta,22xi-trihydroxy-furost-5,25(27)-diene-1beta-yl O-beta-D-galactopyranoside|atropuroside F

C39H62O16 (786.4038)


   
   
   

6alpha,7alpha,15beta,16beta,24-pentacetoxy-22alpha-carbometoxy-21beta,22beta-epoxy-18beta-hydroxy-27,30-bisnor-3,4-secofriedela-1,20(29)-dien-3,4R-olide|LLD-3

6alpha,7alpha,15beta,16beta,24-pentacetoxy-22alpha-carbometoxy-21beta,22beta-epoxy-18beta-hydroxy-27,30-bisnor-3,4-secofriedela-1,20(29)-dien-3,4R-olide|LLD-3

C41H54O15 (786.3463)


   
   

(2R,3R,4S,5R,7S,8S,9S,13S,14S,15R)-5-benzoyloxy-15-hydroxy-7-isobutanoyloxy-2,3,8,9,14-pentaacetoxyjatropha-6(17),11E-diene

(2R,3R,4S,5R,7S,8S,9S,13S,14S,15R)-5-benzoyloxy-15-hydroxy-7-isobutanoyloxy-2,3,8,9,14-pentaacetoxyjatropha-6(17),11E-diene

C41H54O15 (786.3463)


   
   

angudracanoside B

angudracanoside B

C38H58O15S (786.3496)


   

6-O-methylbouvardin

6-O-methylbouvardin

C41H50N6O10 (786.3588)


   

3-O-beta-chacotriosyl-pregna-5-en-3beta,16beta-diol-20-one|solasodoside D

3-O-beta-chacotriosyl-pregna-5-en-3beta,16beta-diol-20-one|solasodoside D

C39H62O16 (786.4038)


   

(E)-3-(4-hydroxyphenyl)-N-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[4-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propyl]amino]butyl]amino]propyl]prop-2-enamide

NCGC00384571-01!(E)-3-(4-hydroxyphenyl)-N-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[4-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propyl]amino]butyl]amino]propyl]prop-2-enamide

C46H50N4O8 (786.3628)


   

C39H62O16_20-Oxopregn-16-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-beta-D-glucopyranoside

NCGC00384853-01_C39H62O16_20-Oxopregn-16-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-beta-D-glucopyranoside

C39H62O16 (786.4038)


   

(E)-3-(4-hydroxyphenyl)-N-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[4-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propyl]amino]butyl]amino]propyl]prop-2-enamide [IIN-based: Match]

NCGC00384571-01!(E)-3-(4-hydroxyphenyl)-N-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[4-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propyl]amino]butyl]amino]propyl]prop-2-enamide [IIN-based: Match]

C46H50N4O8 (786.3628)


   

(E)-3-(4-hydroxyphenyl)-N-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[4-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propyl]amino]butyl]amino]propyl]prop-2-enamide [IIN-based on: CCMSLIB00000847637]

NCGC00384571-01!(E)-3-(4-hydroxyphenyl)-N-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[4-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-[3-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]propyl]amino]butyl]amino]propyl]prop-2-enamide [IIN-based on: CCMSLIB00000847637]

C46H50N4O8 (786.3628)


   

N1,N5,N10,N14-Tetra-trans-p-coumaroylspermine

(2E)-3-(4-hydroxyphenyl)-N-{3-[(2E)-3-(4-hydroxyphenyl)-N-{4-[(2E)-3-(4-hydroxyphenyl)-N-{3-[(2E)-3-(4-hydroxyphenyl)prop-2-enamido]propyl}prop-2-enamido]butyl}prop-2-enamido]propyl}prop-2-enamide

C46H50N4O8 (786.3628)


   

1-(8,12-dihydroxy-7-{3-hydroxy-2-[6-hydroxy-3-(1-hydroxy-3-methylbutyl)-2-methoxybenzoyl]-5-methylphenyl}-4-methoxy-10-methyl-5-oxo-7,8-dihydro-5H-dibenzo[b,h][1,5]dioxonin-3-yl)-3-methylbutyl acetate

1-(8,12-dihydroxy-7-{3-hydroxy-2-[6-hydroxy-3-(1-hydroxy-3-methylbutyl)-2-methoxybenzoyl]-5-methylphenyl}-4-methoxy-10-methyl-5-oxo-7,8-dihydro-5H-dibenzo[b,h][1,5]dioxonin-3-yl)-3-methylbutyl acetate

C44H50O13 (786.3251)


   

PGP(i-12:0/18:1(12Z)-O(9S,10R))

PGP(i-12:0/18:1(12Z)-O(9S,10R))

C36H68O14P2 (786.4084)


   

PGP(18:1(12Z)-O(9S,10R)/i-12:0)

PGP(18:1(12Z)-O(9S,10R)/i-12:0)

C36H68O14P2 (786.4084)


   

PGP(i-12:0/18:1(9Z)-O(12,13))

PGP(i-12:0/18:1(9Z)-O(12,13))

C36H68O14P2 (786.4084)


   

PGP(18:1(9Z)-O(12,13)/i-12:0)

PGP(18:1(9Z)-O(12,13)/i-12:0)

C36H68O14P2 (786.4084)


   
   
   
   
   
   
   
   
   
   
   
   

5'-ODMT cEt m5U Phosphoramidite (Amidite)

5'-ODMT cEt m5U Phosphoramidite (Amidite)

C42H51N4O9P (786.3393)


5'-ODMT cEt m5U Phosphoramidite Amidite is a locked nucleic acid (LNA) analog. 5'-ODMT cEt m5U Phosphoramidite Amidite shows excellent safety and antisense activity[1][2].

   

2-{[2-({8-[(4,5-dihydroxy-6-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-3,7-dimethylocta-2,6-dien-1-yl}oxy)-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[2-({8-[(4,5-dihydroxy-6-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-3,7-dimethylocta-2,6-dien-1-yl}oxy)-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H58O20 (786.3521)


   

(1s,4r,7s,10s,13s,16s,28s)-2,5,11,28-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13s,16s,28s)-2,5,11,28-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

1-(12,17-dihydroxy-11-{3-hydroxy-2-[6-hydroxy-3-(1-hydroxy-3-methylbutyl)-2-methoxybenzoyl]-5-methylphenyl}-7-methoxy-15-methyl-9-oxo-2,10-dioxatricyclo[11.4.0.0³,⁸]heptadeca-1(17),3(8),4,6,13,15-hexaen-6-yl)-3-methylbutyl acetate

1-(12,17-dihydroxy-11-{3-hydroxy-2-[6-hydroxy-3-(1-hydroxy-3-methylbutyl)-2-methoxybenzoyl]-5-methylphenyl}-7-methoxy-15-methyl-9-oxo-2,10-dioxatricyclo[11.4.0.0³,⁸]heptadeca-1(17),3(8),4,6,13,15-hexaen-6-yl)-3-methylbutyl acetate

C44H50O13 (786.3251)


   

(2r,3r)-2-{[(2r)-5-carbamimidamido-2-{[(3s,4r)-4-[(3-{[(2r)-1,2-dihydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene)amino]-1,3-dihydroxy-5-(1h-indol-3-yl)pentylidene]amino}-1-hydroxypentylidene]amino}-3-hydroxy-3-phenylpropanoic acid

(2r,3r)-2-{[(2r)-5-carbamimidamido-2-{[(3s,4r)-4-[(3-{[(2r)-1,2-dihydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene)amino]-1,3-dihydroxy-5-(1h-indol-3-yl)pentylidene]amino}-1-hydroxypentylidene]amino}-3-hydroxy-3-phenylpropanoic acid

C40H50N8O9 (786.3701)


   

(1s,4r,7s,10s,13s,16s)-2,5,11,24-tetrahydroxy-7-[(1r)-1-hydroxyethyl]-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13s,16s)-2,5,11,24-tetrahydroxy-7-[(1r)-1-hydroxyethyl]-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

(1s,4r,7s,10s,13s,16s)-2,5,11,26-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13s,16s)-2,5,11,26-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

(1s,4r,7s,10s,13r,16s,17s)-2,5,11,17-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13r,16s,17s)-2,5,11,17-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

2,5,11,17-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

2,5,11,17-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

[(3s,4r,5r,6s)-4-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-6-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxan-3-yl]oxidanesulfonic acid

[(3s,4r,5r,6s)-4-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-6-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy]oxan-3-yl]oxidanesulfonic acid

C38H58O15S (786.3496)


   

2-[1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3,7-dimethyloct-6-en-1-yl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

2-[1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3,7-dimethyloct-6-en-1-yl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

C49H54O9 (786.3768)


   

2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-{[(2z,6e)-8-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,7-dimethylocta-2,6-dien-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-{[(2z,6e)-8-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,7-dimethylocta-2,6-dien-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H58O20 (786.3521)


   

2-[(1s,3s)-1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3,7-dimethyloct-6-en-1-yl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

2-[(1s,3s)-1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3,7-dimethyloct-6-en-1-yl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

C49H54O9 (786.3768)


   

2,5,11,28-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

2,5,11,28-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

(1s,4r,7r,10r,13s,16s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7r,10r,13s,16s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

(1'r,2s,2'r,3s,4's,5r,7's,8's,9's,10's,12's,13'r,16's)-16'-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',3,8',10'-tetrol

(1'r,2s,2'r,3s,4's,5r,7's,8's,9's,10's,12's,13'r,16's)-16'-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',3,8',10'-tetrol

C39H62O16 (786.4038)


   

(2s,3s)-2-{[(2s)-5-carbamimidamido-2-{[(3r,4s)-4-[(3-{[(2s)-1,2-dihydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene)amino]-1,3-dihydroxy-5-(1h-indol-3-yl)pentylidene]amino}-1-hydroxypentylidene]amino}-3-hydroxy-3-phenylpropanoic acid

(2s,3s)-2-{[(2s)-5-carbamimidamido-2-{[(3r,4s)-4-[(3-{[(2s)-1,2-dihydroxy-3-phenylpropylidene]amino}-1-hydroxypropylidene)amino]-1,3-dihydroxy-5-(1h-indol-3-yl)pentylidene]amino}-1-hydroxypentylidene]amino}-3-hydroxy-3-phenylpropanoic acid

C40H50N8O9 (786.3701)


   

(1s,4r,7s,10r,13s,16s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10r,13s,16s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

methyl 3,4,23,24-tetrakis(acetyloxy)-22-[(acetyloxy)methyl]-11-hydroxy-2,5,15,21-tetramethyl-9,19-dimethylidene-7,20-dioxahexacyclo[13.9.0.0²,¹².0⁵,¹¹.0⁶,⁸.0¹⁶,²²]tetracos-17-ene-6-carboxylate

methyl 3,4,23,24-tetrakis(acetyloxy)-22-[(acetyloxy)methyl]-11-hydroxy-2,5,15,21-tetramethyl-9,19-dimethylidene-7,20-dioxahexacyclo[13.9.0.0²,¹².0⁵,¹¹.0⁶,⁸.0¹⁶,²²]tetracos-17-ene-6-carboxylate

C41H54O15 (786.3463)


   

(1s,4r,7s,10s,13s,16s)-2,5,11,25-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13s,16s)-2,5,11,25-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

(1s,2s,4s,6s,7s,8r,9s,12s,13r,14s,15s,16r)-7,9,13-trimethyl-14-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-6,15,16-triol

(1s,2s,4s,6s,7s,8r,9s,12s,13r,14s,15s,16r)-7,9,13-trimethyl-14-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-6,15,16-triol

C39H62O16 (786.4038)


   

(1s,4r,7s,10s,13s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

methyl (1s,2r,3s,4r,5r,6s,8r,11r,12r,15s,16s,21r,22r,23r,24s)-3,4,23,24-tetrakis(acetyloxy)-22-[(acetyloxy)methyl]-11-hydroxy-2,5,15,21-tetramethyl-9,19-dimethylidene-7,20-dioxahexacyclo[13.9.0.0²,¹².0⁵,¹¹.0⁶,⁸.0¹⁶,²²]tetracos-17-ene-6-carboxylate

methyl (1s,2r,3s,4r,5r,6s,8r,11r,12r,15s,16s,21r,22r,23r,24s)-3,4,23,24-tetrakis(acetyloxy)-22-[(acetyloxy)methyl]-11-hydroxy-2,5,15,21-tetramethyl-9,19-dimethylidene-7,20-dioxahexacyclo[13.9.0.0²,¹².0⁵,¹¹.0⁶,⁸.0¹⁶,²²]tetracos-17-ene-6-carboxylate

C41H54O15 (786.3463)


   

2,5,11,24-tetrahydroxy-7-(1-hydroxyethyl)-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

2,5,11,24-tetrahydroxy-7-(1-hydroxyethyl)-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

(1s,4r,7s,10s,13s,16s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

(1s,4r,7s,10s,13s,16s)-2,5,11-trihydroxy-7-(hydroxymethyl)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,9,13,15,29-pentamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)


   

2-[(5-carbamimidamido-2-{[4-({3-[(1,2-dihydroxy-3-phenylpropylidene)amino]-1-hydroxypropylidene}amino)-1,3-dihydroxy-5-(1h-indol-3-yl)pentylidene]amino}-1-hydroxypentylidene)amino]-3-hydroxy-3-phenylpropanoic acid

2-[(5-carbamimidamido-2-{[4-({3-[(1,2-dihydroxy-3-phenylpropylidene)amino]-1-hydroxypropylidene}amino)-1,3-dihydroxy-5-(1h-indol-3-yl)pentylidene]amino}-1-hydroxypentylidene)amino]-3-hydroxy-3-phenylpropanoic acid

C40H50N8O9 (786.3701)


   

4-({4-[(2-{[2-amino-5-(4-carboxy-n-hydroxy-3-methylbut-2-enamido)-1-hydroxypentylidene]amino}-5-(4-carboxy-n-hydroxy-3-methylbut-2-enamido)-1-hydroxypentylidene)amino]-4-carboxybutyl}(hydroxy)carbamoyl)-3-methylbut-3-enoic acid

4-({4-[(2-{[2-amino-5-(4-carboxy-n-hydroxy-3-methylbut-2-enamido)-1-hydroxypentylidene]amino}-5-(4-carboxy-n-hydroxy-3-methylbut-2-enamido)-1-hydroxypentylidene)amino]-4-carboxybutyl}(hydroxy)carbamoyl)-3-methylbut-3-enoic acid

C33H50N6O16 (786.3283)


   

(3z)-4-{[(4s)-4-{[(2s)-2-{[(2s)-2-amino-5-[(2z)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]-1-hydroxypentylidene]amino}-5-[(2z)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]-1-hydroxypentylidene]amino}-4-carboxybutyl](hydroxy)carbamoyl}-3-methylbut-3-enoic acid

(3z)-4-{[(4s)-4-{[(2s)-2-{[(2s)-2-amino-5-[(2z)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]-1-hydroxypentylidene]amino}-5-[(2z)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]-1-hydroxypentylidene]amino}-4-carboxybutyl](hydroxy)carbamoyl}-3-methylbut-3-enoic acid

C33H50N6O16 (786.3283)


   

{4-hydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-6-{7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy}oxan-3-yl}oxidanesulfonic acid

{4-hydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-6-{7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-16'-oloxy}oxan-3-yl}oxidanesulfonic acid

C38H58O15S (786.3496)


   

7,9,13-trimethyl-14-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-6,15,16-triol

7,9,13-trimethyl-14-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)but-3-en-1-yl]-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-6,15,16-triol

C39H62O16 (786.4038)


   

16'-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',3,8',10'-tetrol

16'-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',3,8',10'-tetrol

C39H62O16 (786.4038)


   

2,5,11,25-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

2,5,11,25-tetrahydroxy-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.2¹⁸,²¹.1²³,²⁷]tritriaconta-2,5,11,18,20,23(31),24,26,32-nonaene-8,14,30-trione

C41H50N6O10 (786.3588)